Jefferies Group’s Agios Pharmaceuticals AGIO Stock Holding History

Jefferies Group’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,010	Closed	-$377K	–	1618
2022 Q2	$377K	Buy	17,010 +3,418	+25%	+$77.2K	﹤0.01%	1096
2022 Q1	$396K	Buy	+13,592	New	+$415K	﹤0.01%	1109
2021 Q3	–	Sell	-5,383	Closed	-$297K	–	1688
2021 Q2	$297K	Buy	+5,383	New	+$301K	﹤0.01%	1308
2021 Q1	–	Sell	-8,132	Closed	-$352K	–	1585
2020 Q4	$352K	Sell	8,132 -2,746	-25%	-$109K	﹤0.01%	1239
2020 Q3	$381K	Buy	+10,878	New	+$477K	﹤0.01%	1047
2020 Q2	–	Sell	-40,000	Closed	-$1.42M	–	1259
2020 Q1	$1.42M	Buy	40,000 +20,507	+105%	+$948K	0.02%	843
2019 Q4	$931K	Sell	19,493 -34,535	-64%	-$1.31M	0.01%	1502
2019 Q3	$1.75M	Buy	+54,028	New	+$2.24M	0.01%	1173
2017 Q1	–	Sell	-500	Closed	-$21K	–	2288
2016 Q4	$21K	Buy	+500	New	+$26.2K	﹤0.01%	2129
2016 Q2	–	Sell	-11,623	Closed	-$574K	–	2100
2016 Q1	$472K	Sell	11,623 -15,031	-56%	-$643K	﹤0.01%	1484
2015 Q4	$1.73M	Buy	+26,654	New	+$1.75M	0.01%	935
2015 Q3	–	Sell	-8,600	Closed	-$841K	–	2230
2015 Q2	$956K	Buy	+8,600	New	+$926K	﹤0.01%	1259

Other funds holding AGIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Group's AGIO Position: Q3 2022 in Review

Jefferies Group sold out of Agios Pharmaceuticals (AGIO) in Q3 2022, closing a stake of 17,010 shares — an estimated $377K sold.

Jefferies Group first reported a position in AGIO in Q2 2015 and held it in 12 quarters. The position peaked at $1.75M in Q3 2019. 168 funds tracked by Wall St. Rank hold AGIO as of Q3 2022.

Jefferies Group reported no remaining Agios Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Jefferies Group sold 17,010 Agios Pharmaceuticals shares in Q3 2022, an estimated $377K.
Jefferies Group first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 12 quarters.
Jefferies Group's Agios Pharmaceuticals position peaked at $1.75M in Q3 2019.
168 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.